158 related articles for article (PubMed ID: 6350663)
21. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
Tanjoh K; Tomita R; Hayashi N
Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
[TBL] [Abstract][Full Text] [Related]
22. Insulin and glucagon secretion after pancreatectomies. Correlation of secretion and hormonal contents of remaining pancreas.
Gotoh M; Monden M; Okamura J; Mori T; Shima K
Diabetes; 1989 Jul; 38(7):861-7. PubMed ID: 2661285
[TBL] [Abstract][Full Text] [Related]
23. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
Matsuyama T; Tanaka R; Shima K; Tarui S
Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal gastropancreatic modulations for the release of somatostatin-like immunoreactivity, glucagon, and insulin in the rat.
Marre M; Miller J; Helman AM; Assan R
Diabetes; 1983 Aug; 32(8):768-73. PubMed ID: 6347773
[TBL] [Abstract][Full Text] [Related]
25. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
[TBL] [Abstract][Full Text] [Related]
26. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
[TBL] [Abstract][Full Text] [Related]
27. The role of glucagon deficiency in the Houssay phenomenon of dogs.
Nakabayashi H; Dobbs RE; Unger RH
J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
[TBL] [Abstract][Full Text] [Related]
28. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
[TBL] [Abstract][Full Text] [Related]
29. Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs.
Holst JJ; Kreutzfeldt M; Holm G; Jensen E; Poulsen JS; Sparsö B; Sparsö B; Schmidt A
Diabete Metab; 1978 Jun; 4(2):75-9. PubMed ID: 680313
[TBL] [Abstract][Full Text] [Related]
30. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
Ross G; Lickley L; Vranic M
Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
[TBL] [Abstract][Full Text] [Related]
31. [Influence of upper abdominal autonomic denervation on pancreatic and gut hormone secretion].
Takaesu Y
Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1584-90. PubMed ID: 3431538
[TBL] [Abstract][Full Text] [Related]
32. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
[TBL] [Abstract][Full Text] [Related]
33. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
34. Gut-hormone profile in totally pancreatectomised patients.
Dammann HG; Besterman HS; Bloom SR; Schreiber HW
Gut; 1981 Feb; 22(2):103-7. PubMed ID: 7215941
[TBL] [Abstract][Full Text] [Related]
35. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
36. The effect of phenformin upon the plasma pancreatic and gut glucagon-like immunoreactivity in diabetics.
Czyzyk A; Heding LG; Malczewski B; Miedzinska E
Diabetologia; 1975 Apr; 11(2):129-33. PubMed ID: 168107
[TBL] [Abstract][Full Text] [Related]
37. Plasma glucagon-like immunoreactivity (GLI) in dogs.
Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
[TBL] [Abstract][Full Text] [Related]
38. Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.
Muller WA; Berger M; Suter P; Cüppers HJ; Reiter J; Wyss T; Berchtold P; Schmidt FH; Assal JP; Renold AE
J Clin Invest; 1979 May; 63(5):820-7. PubMed ID: 447830
[TBL] [Abstract][Full Text] [Related]
39. Gastric A-cell function in insulin-deprived depancreatized dogs.
Blazquez E; Muñoz-Barragan L; Patton GS; Orci L; Dobbs RE; Unger RH
Endocrinology; 1976 Nov; 99(5):1182-8. PubMed ID: 991814
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic A-cell function in the partially pancreatectomized Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus.
Zhu M; Mizuno A; Noma Y; Sano T; Shima K
Metabolism; 1996 Nov; 45(11):1360-7. PubMed ID: 8931640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
